Friday, November 13, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· May 11, 2026

Exodus Reports First Quarter 2026 Results

View original at globenewswire.com
“Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced its unaudited results for the first quarter ended March 31, 2026. ... Net loss $(32.1) [in USD millions for Q1 2026]”
Verbatim excerpt from the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Net loss in Q1 2026 was $32.1 million, compared to $12.9 million in Q1 2025, a 149% increase in losses year-over-year

    60% confidence

  • Exchange provider processed volume was $1.18 billion in Q1 2026, down 26% from Q4 2025

    60% confidence

  • Top assets traded in Q1 2026 were Bitcoin (29%), Tether TRX Network (14%), Tether ETH Network (11%), ETH (9%), and USDC ETH Network (7%) of volume

    60% confidence

  • Quarterly funded users were 1.4 million at end of Q1 2026, down 18% from 1.7 million as of December 31, 2025

    60% confidence

  • XO Swap's share of exchange volume has grown steadily since launch, reflecting demand for best-execution routing across liquidity sources

    60% confidence

  • B2B swap partners generated $257 million in Q1 2026 volume, representing 22% of the quarterly total exchange volume

    60% confidence

  • Monavate and Baanx are established providers of card and payments infrastructure, serving fintech, crypto, and enterprise clients worldwide

    60% confidence

  • Total digital assets, cash, and cash equivalents were $122.6 million as of March 31, 2026, including $42.8M Bitcoin, $3.9M Ether, and $74.4M cash, cash equivalents, and stablecoins

    60% confidence

  • Full-time equivalent team members were approximately 220 as of March 31, 2026, up 5 from December 31, 2025

    60% confidence

  • Exodus monthly active users were 1.5 million as of March 31, 2026, unchanged from December 31, 2025

    60% confidence

  • General and administrative expense was $15.5 million in Q1 2026, up 8% from $14.3 million in Q1 2025

    60% confidence

  • Loss on digital assets, net was $36.4 million in Q1 2026, compared to $28.8 million in Q1 2025, a 26% increase

    60% confidence

  • Average customer response time was less than 60 minutes in Q1 2026

    60% confidence

  • Technology, development and user support expense was $16.2 million in Q1 2026, up 9% from $14.9 million in Q1 2025

    60% confidence

  • Q1 2026 revenue was $22.7 million, down 37% from $36.0 million in Q1 2025

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com